CAS 1240390-27-5
:GSK143
Description:
GSK143, also known by its chemical name and CAS number 1240390-27-5, is a small molecule that has been investigated primarily for its potential therapeutic applications. It is recognized as a selective inhibitor of certain enzymes, particularly those involved in the modulation of cellular signaling pathways. The compound has shown promise in preclinical studies for its ability to influence processes such as inflammation and cell proliferation, making it a candidate for research in various disease models, including cancer and autoimmune disorders. GSK143's structure typically features functional groups that enhance its binding affinity and specificity for target proteins. As with many investigational compounds, its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), are critical for determining its efficacy and safety profile. Ongoing research aims to elucidate its mechanism of action and potential therapeutic benefits, although detailed clinical data may still be limited. As with any investigational drug, further studies are necessary to fully understand its characteristics and applications in medicine.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
GSK143
CAS:<p>GSK143: Oral SYK inhibitor, pIC50=7.5, curbs pErk, anti-inflammatory, hinders immune cells in mice.</p>Formula:C17H22N6O2Color and Shape:SolidMolecular weight:342.403GSK143
CAS:<p>GSK143 is a peptide that activates an antibody and receptor to induce cell death. It has been shown to be a potent inhibitor of ion channels, including calcium channels and potassium channels. GSK143 also interacts with a variety of proteins in the cell, such as ligands and receptors, which may be used to study receptor-ligand interactions. GSK143 is soluble in water and has a purity of > 99% (HPLC).</p>Formula:C17H22N6O2Purity:Min. 95%Molecular weight:342.4 g/mol
